Genelux GNLX
NASDAQ GNLX
$2.48 -0.04 (-1.59%)
At close: Sep 10, 2026 · 4:00 PM EDT

Genelux (GNLX) EBT Margin (2022 - 2024)

Genelux (GNLX) posted EBT Margin of 98125.0% for Q1 2024, down 1642.71% on a QoQ basis from 5630.59% in Q1 2023, and down 9249441.0% year-over-year from N/an in Q2 2023.

Analysis

Genelux (GNLX) EBT Margin (2022 - 2024) Analysis & Trends

Genelux has reported EBT Margin for 3 years, with the latest figure at 98125.0% in Q1 2024.

  • On a quarterly basis, EBT Margin fell 9249441.0% year-over-year to 98125.0% in Q1 2024; TTM through Dec 2024 was 385562.5%, a 36961956.0% decrease from a year earlier, with the FY2025 full-year figure at 406287.5%, down 1883750.0% from the prior year.
  • EBT Margin was 98125.0% for Q1 2024 at Genelux, down from 5630.59% in the prior quarter.
  • The five-year high for EBT Margin was 54.63% in Q3 2022, with the low at 98125.0% in Q1 2024.
  • Average EBT Margin over 3 years is 27210.17%, with a median of 5385.15% recorded in 2022.
  • The largest YoY upside for EBT Margin was 9249441 bps in 2024 against a maximum downside of 9249441 bps in 2024.
  • Over 3 years, EBT Margin stood at 5139.71% in 2022, then slipped by 10 bps to 5630.59% in 2023, then sank by 1643 bps to 98125.0% in 2024.
  • The last three EBT Margin figures came in at 98125.0% (Q1 2024), 5630.59% (Q1 2023), and 5139.71% (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 27.53%
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -131.41%
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 41.75%
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 35.61%
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 35.78%
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -528.97%
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 13.77%
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 4.84%
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -20,427.46%
10 Genelux 108.17 Mn 108.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -98,125.00%
Mar 31, 2023 -5,630.59%
Dec 31, 2022 -5,139.71%
Sep 30, 2022 54.63%